Checkmate 067: A phase III randomized double-blind study of nivolumab (NIVO) monotherapy or NIVO combined with pilimumab (IPI) versus IPI monotherapy in previously untreated patients (PTS) with advanced melanoma (MEL) Meeting Abstract
| Authors: | Wolchok, J. D.; Chiarion-Sileni, V.; Gonzalez, R.; Rutkowski, P.; Grob, J. J.; Cowey, C. L.; Lao, C. D.; Schadendorf, D.; Ferrucci, P. F.; Smylie, M.; Dummer, R.; Hill, A.; Haanen, J.; Maio, M.; McArthur, G.; Yang, A.; Rollin, L.; Horak, C.; Larkin, J.; Hodi, F. S. |
| Abstract Title: | Checkmate 067: A phase III randomized double-blind study of nivolumab (NIVO) monotherapy or NIVO combined with pilimumab (IPI) versus IPI monotherapy in previously untreated patients (PTS) with advanced melanoma (MEL) |
| Meeting Title: | MOGA Annual Scientific Meeting 2015 |
| Journal Title: | Asia-Pacific Journal of Clinical Oncology |
| Volume: | 11 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2015 Aug 5-7 |
| Meeting Location: | Hobart, Australia |
| ISSN: | 1743-7555 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2015-08-01 |
| Start Page: | 68 |
| Language: | English |
| ACCESSION: | WOS:000357957300069 |
| PROVIDER: | wos |
| DOI: | 10.1111/ajco.12398 |
| Notes: | Meeting Abstract -- 3 -- SI -- Source: Wos |
